课题基金 / 基金详情

PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH

PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH
瑞波西汀在健康志愿者体内的药代动力学
批准号:
6306598
负责人:
RUSSELL Elliott POLAND
金额:
$0.1万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30

项目摘要

项目成果

RUSSELL Elliott POLAND的其他基金

相似基金

相关文献

中文摘要
翻译
大量研究表明,种族可以影响多种药物的药代动力学。在某种程度上,这是由于肝脏中参与药物代谢的P450酶(大部分)的活性不同。为了进一步了解这一问题,我们将对一种新的抗抑郁药瑞波西汀在非裔美国人、亚洲人(中国人)和白种人正常志愿者中的药代动力学进行评估。瑞波西汀目前在欧洲被批准用于治疗抑郁症,目前正在进行该化合物的III期研究。”
英文摘要
Numerous studies indicate that ethnicity can influence the pharmacokinetics of a variety of pharmacologic agents. In part, this is due to differences in the act- ivity of P450 enzymes (mostly) in the liver which are involved in drug metabol- ism. In order to understand this issue further, evaluation of the pharmacokinet- ics of a new antidepressant, Reboxetine, in African-American, Asian (Chinese) and Caucasian normal volunteers will be done. Reboxetine is currently approved in Europe for the treatment of depression and currently Phase III studies are being performed with the compound."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treatment of Depression with Massage in End of Life AIDS
  • 批准号:
    6447252
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2001
  • 负责人:
    RUSSELL Elliott POLAND
  • 依托单位:
Developmental Exposure to Nicotine
  • 批准号:
    6644183
  • 项目类别:
  • 资助金额:
    $15.3万
  • 财政年份:
    2001
  • 负责人:
    RUSSELL Elliott POLAND
  • 依托单位:
Ethnic Variations in Antidepressant Response
  • 批准号:
    6647056
  • 项目类别:
  • 资助金额:
    $22.95万
  • 财政年份:
    2001
  • 负责人:
    RUSSELL Elliott POLAND
  • 依托单位:
Ethnic Variations in Antidepressant Response
  • 批准号:
    6399285
  • 项目类别:
  • 资助金额:
    $22.95万
  • 财政年份:
    2001
  • 负责人:
    RUSSELL Elliott POLAND
  • 依托单位:
海外基金